Assessment of regulatory needs list

Assessment of regulatory needs list

The assessment of regulatory needs list includes substances for which an assessment either is under development or has been completed. 

For each substance, the table shows the assessing authority (submitter), the concern, the status and the suggested follow-up action, and the date of the latest update to the list entry.

Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.

Regulatory Management Option Analysis (RMOA) are assessments of regulatory needs. Publication of RMOA was initiated in February 2013 with the start of the implementation of the SVHC Roadmap. In 2019, authorities and in particular ECHA have moved to address more groups of substances.

The responsibility for the content of an assessment of regulatory needs rests with the authority that developed it. It is possible that other authorities do not have the same view and may develop a further assessment of regulatory needs for the same (group of) substances. Assessment of regulatory needs and their conclusions are compiled based on available information and may change in light of new information or further assessment.  

Last updated 13 September 2021. Database contains 268 unique substances/entries.
Filter the list
Date of intention:
Date of RMOA conclusion:
Latest update:

The List does not contain any Substances.
 
202-039-0
91-08-7
Germany
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
202-039-0
91-08-7
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
23/09/2014
Details
211-765-7
693-98-1
Sweden
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
19/12/2019
Details
202-112-7
91-97-4
Germany
Mutagenic
Persistence
Respiratory sensitiser
Skin sensitiser
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
223-861-6
4098-71-9
Sweden
Exposure
Mutagenic
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
None
09/02/2018
Details
223-861-6
4098-71-9
Germany
Carcinogenic
Exposure
Mutagenic
Other human toxicity
Concluded
Appropriate to initiate regulatory risk management action
Restriction
10/10/2019
Details
201-025-1
77-40-7
France
Endocrine disruption
Under development
Under development
No suggestion yet
07/03/2017
Details
216-036-7
1478-61-1
Sweden
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
CLH
20/12/2018
Details
201-245-8
80-05-7
Germany
Aggregated tonnage
Endocrine disruption
Widespread use
Concluded
Appropriate to initiate regulatory risk management action
SVHC
15/08/2017
Details
201-245-8
80-05-7
France
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
15/08/2017
Details
226-378-9
5384-21-4
France
Endocrine disruption
Persistence
Toxic for reproduction
Widespread use
Under development
Under development
No suggestion yet
11/03/2016
Details
225-863-2
5124-30-1
Germany
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
210-658-2
620-92-8
Sweden
Endocrine disruption
Other human toxicity
Concluded
Appropriate to initiate regulatory risk management action
CLH
30/03/2021
Details
202-966-0
101-68-8
Denmark
Carcinogenic
Mutagenic
Other human toxicity
Persistence
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
23/09/2014
Details
202-966-0
101-68-8
Germany
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
254-551-9
39635-79-5
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Pending
On hold
No suggestion yet
10/10/2019
Details
201-250-5
80-09-1
Belgium
Carcinogenic
Endocrine disruption
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
06/03/2015
Details
250-863-4
31906-04-4
Sweden
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
Other
05/06/2015
Details
202-681-1
98-56-6
Netherlands
Carcinogenic
Under development
Under development
No suggestion yet
09/11/2017
Details
209-544-5
584-84-9
Germany
Bioaccumulation
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
10/10/2019
Details
209-544-5
584-84-9
Denmark
Aggregated tonnage
Carcinogenic
Exposure
Mutagenic
Widespread use
Concluded
No need to initiate further regulatory risk management action at this time
None
10/10/2019
Details
241-533-0
17540-75-9
Sweden
Bioaccumulation
Persistence
Under development
Under development
No suggestion yet
19/10/2020
Details
202-696-3
98-73-7
Belgium
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
23/09/2014
Details
202-679-0
98-54-4
Germany
Endocrine disruption
Other human toxicity
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/10/2019
Details
204-327-1
119-47-1
Denmark
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
12/07/2021
Details
217-533-1
1879-09-0
France
Carcinogenic
Mutagenic
Skin sensitiser
Toxic for reproduction
Under development
Under development
No suggestion yet
07/03/2017
Details
677-811-7
207386-91-2
Denmark
Endocrine disruption
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
13/09/2021
Details
255-288-2
41272-40-6
Netherlands
Carcinogenic
Mutagenic
Skin sensitiser
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
CLH
15/12/2017
Details
235-715-9
12607-70-4
France
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
23/09/2014
Details
201-469-6
83-32-9
France
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
11/12/2015
Details
203-466-5
107-13-1
Germany
Mutagenic
Other human toxicity
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
23/09/2014
Details
400-370-7
63231-51-6
Finland
Bioaccumulation
Other environmental toxicity
Persistence
Concluded
Appropriate to initiate regulatory risk management action
Other
03/03/2020
Details
287-477-0
85535-85-9
United Kingdom
Bioaccumulation
Persistence
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
Restriction
12/12/2019
Details
287-477-0
85535-85-9
Germany
Carcinogenic
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
19/10/2020
Details
-
-
Netherlands
Carcinogenic
Exposure
Mutagenic
STOT RE
Under development
Under development
No suggestion yet
13/04/2017
Details
629-719-3
1219010-04-4
Sweden
STOT RE
Concluded
No need to initiate further regulatory risk management action at this time
None
26/04/2019
Details
292-562-0
90640-43-0
Sweden
STOT RE
Concluded
No need to initiate further regulatory risk management action at this time
None
17/04/2019
Details
268-957-9
68155-37-3
Sweden
Carcinogenic
Mutagenic
Respiratory sensitiser
Skin sensitiser
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
17/04/2019
Details
696-364-9
133779-11-0
Sweden
STOT RE
Concluded
No need to initiate further regulatory risk management action at this time
None
17/04/2019
Details
232-565-6
9000-90-2
United Kingdom
Respiratory sensitiser
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
Other
12/09/2018
Details
200-539-3
62-53-3
Netherlands
Other environmental toxicity
Other human toxicity
Concluded
No need to initiate further regulatory risk management action at this time
None
05/07/2017
Details
233-660-5
10294-40-3
Netherlands
Carcinogenic
Concluded
Appropriate to initiate regulatory risk management action
CLH
SVHC
08/07/2019
Details
200-280-6
56-55-3
Germany
Bioaccumulation
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
05/07/2017
Details
209-008-0
552-30-7
Netherlands
Mutagenic
Skin sensitiser
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
11/03/2016
Details
205-883-8
191-24-2
Germany
Bioaccumulation
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
05/07/2017
Details
205-916-6
207-08-9
Germany
Bioaccumulation
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
05/07/2017
Details
202-859-9
100-51-6
Germany
Carcinogenic
Mutagenic
Respiratory sensitiser
STOT RE
Toxic for reproduction
Under development
Under development
No suggestion yet
24/06/2020
Details
231-150-7
7440-41-7
Germany
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Other
19/12/2016
Details
215-133-1
1304-56-9
Netherlands
Carcinogenic
Under development
Under development
No suggestion yet
09/11/2017
Details
205-594-7
143-24-8
Austria
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
05/06/2020
Details

Export search results to:

EU Privacy Disclaimer

This website uses cookies to ensure you get the best experience on our websites.